Unlocking the Potential of IGHV4-80 as a Drug Target and Biomarker

Target Name: IGHV4-80

NCBI ID: G28390

IGHV4-80

Other Name(s): Immunoglobulin heavy variable 4-80 (pseudogene) | immunoglobulin heavy variable 4-80 (pseudogene) | 4-80P | IGHV480

Unlocking the Potential of IGHV4-80 as a Drug Target and Biomarker

Immunoglobulin heavy variable 4-80 (IGHV4-80), also known as human growth factor 1 (HGF1), is a 130-kDa transmembrane glycoprotein that plays a critical role in the regulation of cell growth, differentiation, and survival. IGHV4-80 is a pseudogene, which means that it encodes a protein that is highly similar to the one it is derived from, but may have a different isoelectric point or other properties due to genetic variations.

The discovery of IGHV4-80 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. In this article, we will explore the biology and functions of IGHV4-80, as well as its potential as a drug target and biomarker.

Biography of IGHV4-80

IGHV4-80 is a transmembrane glycoprotein that consists of 118 amino acids. It has a molecular weight of 130 kDa and a calculated pI of 7.12. IGHV4-80 is expressed in various tissues and cells throughout the body, including liver, spleen, thymus, and peripheral blood cells. It is also expressed in the placenta, which suggests a potential role in fetal development and growth.

IGHV4-80 is involved in various physiological processes, including cell growth, differentiation, and survival. It has been shown to play a role in the regulation of cell adhesion, migration, and survival. IGHV4-80 has also been shown to play a role in the regulation of inflammation and fibrosis.

As a pseudogene, IGHV4-80 is derived from a gene that encodes the antibody heavy chain. However, IGHV4-80 has distinct differences from its antibody counterpart, including a different isoelectric point and a different distribution in the cell. These differences may have implications for its function and potential as a drug target.

Drug Target Potential

IGHV4-80 has been identified as a potential drug target due to its unique structure and biology. One of the key features of IGHV4-80 is its extracellular domain, which consists of a hinge region and a leucine-rich region (LRR). The hinge region of IGHV4-80 contains a unique type of Turn-I motif, which has been shown to be involved in the regulation of protein stability and stability-dependent signaling.

The LRR of IGHV4-80 has also been shown to be involved in the regulation of cell growth and differentiation. IGHV4-80 has been shown to play a role in the regulation of cell adhesion and migration, as well as the regulation of cell survival.

In addition to its role in cell biology, IGHV4-80 has also been shown to play a role in the regulation of inflammation and fibrosis. Its involvement in these processes makes it an attractive potential drug target for diseases that are characterized by inflammation and fibrosis, such as cancer, autoimmune diseases, and chronic obstructive pulmonary disease (COPD).

Biomarker Potential

IGHV4-80 has also been shown to be a potential biomarker for various diseases. Its involvement in cell biology and the regulation of inflammation and fibrosis makes it an attractive candidate for the diagnosis and monitoring of these diseases.

One of the key challenges in the development of IGHV4-80 as a biomarker is its limited expression and stability in various tissues. This has led to concerns about its suitability as a diagnostic marker, as well as its potential as a therapeutic target. However, recent studies have shown that IGHV4-80 can be successfully expressed and stabilized in various tissues, including blood cells, liver, and spleen.

In addition to its potential as a biomarker, IGHV4-80 has also been shown to have potential as a therapeutic target. Its unique structure and biology make it an attractive candidate for small molecule inhibitors, antibodies, or other therapeutic approaches.

Conclusion

In conclusion, IGHV4-80 is a pseudogene that has distinct differences from its antibody counterpart, including its unique structure and biology. Its involvement in various physiological processes makes it an attractive potential drug target for diseases characterized by inflammation and fibrosis. As a potential biomarker, IGHV4-80 has the potential to revolutionize the diagnosis and monitoring of these diseases. Further research is needed to fully understand its potential as a drug target and biomarker.

Protein Name: Immunoglobulin Heavy Variable 4-80 (pseudogene)

The "IGHV4-80 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IGHV4-80 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets